The value of supplemental prone imaging in low-dose CT lung cancer screening. A technical note
Abstract
This technical note presents our experience with the additional prone examination of patients during low dose CT lung cancer screening. The prone examination adds only a minor amount of radiation and time to the study and can reduce false positive findings that are gravity-dependent.
Keywords
References
- The National Lung Screening Trial Research Team: Reduced lung-cancer mortality with low-dose computed tomography screening. N Engl J Med 2011;365:395-409. DOI: https://doi.org/10.1056/NEJMoa1102873
- De Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT scanning in a randomized trial. N Engl J Med 2020;382:503-13. DOI: https://doi.org/10.1056/NEJMoa1911793
- Ebell MH, Bentivegna M, Hulme C. Cancer-specific mortality, all-cause mortality and overdiagnosis in lung cancer screening trials: a meta-analysis. Ann Fam Med 2020;18:545-52. DOI: https://doi.org/10.1370/afm.2582
- Kissinger LS, Anderson C, Kim J, et al. Implementation of lung cancer screening in the veterans health administration. J AMA Intern Med 2017;177:399-406.
- Chung JH, Richards JC, Koelsch TL, et al. Screening for lung cancer: Incidental pulmonary parenchymal findings. AJR Am J Roentgenol 2018;210:503-13. DOI: https://doi.org/10.2214/AJR.17.19003
- Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial lung abnormalities: State of the art. Radiology 2021;301:19-34. DOI: https://doi.org/10.1148/radiol.2021204367
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.